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Cyanobacteria are abundant in marine, brack-
ish, and fresh waters. During the past decades, 
cyano  bacterial poisonings of aquatic and ter-
restrial animals as well as humans (Kuiper-
Goodman et al. 1999) have been reported 
worldwide, especially in conjunction with 
cyano  bacterial blooms in water reservoirs, riv-
ers, lakes, and ponds used for drinking water 
or recreational purposes or as water resources 
for livestock. Current research suggests that 
climate change, specifically global warming, 
will promote the incidence and severity of 
cyano  bacterial mass occurrences (Carmichael 
2008; Paerl and Huisman 2008; Paul 2008), 
thereby increasing the potential threat posed 
by cyano  bacterial toxins to human health and 
livestock (World Health Organization 1999).
Microcystin (MC), the most common 
fresh  water cyanotoxin, represents a group of 
cyclic hepta  peptides encompassing > 80 struc-
tural variants (Meriluoto and Spoof 2008), 
with molecular weights ranging between 
900 and 1,100 Da (Zurawell et al. 2005). 
Their inherent capability for inhibiting serine/ 
threonine-specific protein phosphatases (PPs; 
e.g., PP1, PP2A, PP4, PP5) via covalent bind-
ing to the PP catalytic subunit (Hastie et al. 
2005) results, once taken up into the cell, in a 
disruption of cellular phosphorylation/dephos-
phorylation homeo  stasis. This in turn leads 
to several downstream responses, such as dis-
integration of cyto  skeletal structure, inhibition 
of gluconeo  genesis, and enhanced glycolysis 
(Batista et al. 2003; Falconer and Yeung 1992), 
frequently with later onset of apoptosis and 
necrosis (Fladmark et al. 1999; Komatsu et al. 
2007). However, to exert the MC-specific PP 
inhibition, sufficient concentrations of MC 
must enter the cell. Cellular uptake of MCs 
has been demon  strated to occur exclusively 
via an active transport, whereas passive trans-
membrane diffusion can be excluded (Eriksson 
et al. 1990; Fischer et al. 2005; Komatsu et al. 
2007). Consequently, pathological changes 
following MC intoxica  tions are restricted to 
organs, tissues, and cells capable of actively 
transporting MC from the blood into the cell. 
Indeed, active trans  membrane transport of 
MCs is mediated by specific organic anion-
transporting polypeptides (human OATP/
rodent Oatp). Approximately 80 OATPs/
Oatps have been identified from 13 differ-
ent species. In the human, mouse, and rat, 
36 different OATPs/Oatps have been found 
(Hagenbuch 2007; Hagenbuch and Meier 
2004); these can be expressed either ubiqui-
tously (e.g., OATP1A2) or with tissue/organ-
specific expression (e.g., OATP1B1 and 1B3 
in the liver) (Hagenbuch and Meier 2004). 
However, not all OATPs/Oatps are capable 
of transporting MCs (Fischer et al. 2005), 
and different OATPs/Oatps appear to have 
largely differing affinities and capacities for 
MC congeners (Feurstein et al. 2009; Monks 
et al. 2007). Thus, these differing affinities and 
capacities highlight the fact that OATPs/Oatps 
capable of transporting MCs need to be func-
tionally expressed in a tissue/organ or cell type 
such that MCs can exert a cyto  toxic effect. 
Indeed, this has been demon  strated convinc-
ingly with Oatp1b2 knockout mice, which 
were resistant to the overt hepatotoxicity of 
the MC congener MC-LR observed in cor-
responding wild-type mice (Lu et al. 2008). In 
consequence, the often-quoted hepato  toxicity 
and nephro  toxicity of MCs are the result of a 
hepatic first-pass and subsequent renal elimi-
nation effect in organs having a high level of 
functionally expressed OATPs/Oatps capa-
ble of MC transport. More recently, several 
OATPs/Oatps were described in the blood–
brain barrier (BBB), in the blood–  cerebrospinal 
fluid barrier (BCSFB), in human gliomas, and 
in glia cells (Bronger et al. 2005; Huber et al. 
2007; Westholm et al. 2009). Therefore, it 
may be assumed that MCs are able to enter the 
brain and to exert neuro  toxic effects. Indeed, 
116 (89%) of 131 patients of a hemo  dialysis 
unit in Caruaru, Brazil, accidentally exposed 
to MC congeners via dialysis water (specifically 
MC-LR, MC-YR, and MC-AR) (Carmichael 
et al. 2001; Pouria et al. 1998) presented 
with acute symptoms of neuro  toxicity (e.g., 
deafness, tinnitus, reversible blindness). 
Subsequently, 100 patients developed liver fail-
ure, of which 76 died (Carmichael et al. 2001; 
Pouria et al. 1998). Furthermore, a reduc-
tion in brain size was reported in progeny of 
Swiss Albino mice exposed to cyano  bacterial 
bloom extract containing MCs (Falconer et al. 
1988), thus suggesting that MCs have an effect 
on the brain. Whether the observed neuro-
logical effects in the Caruaru patients stem 
from an effect of MCs on the endothelium 
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of the BBB with subsequent in situ ischemia 
and inflammatory reactions, or a direct uptake 
of MCs via OATPs of the BBB endothelium 
(Cecchelli et al. 2007) and OATPs of astro-
cytes, microglia, and/or neurons, remains to 
be resolved. Recently, acute MC congener–
dependent cyto  toxicity as well as the presence 
of murine Oatps (mOatps) was demon  strated 
in primary murine whole-brain cells (Feurstein 
et al. 2009); however, that study did not dif-
ferentiate between the various cell types 
affected, such as astrocytes, microglia, or   
neurons. Thus, although the literature strongly 
suggests the presence of OATPs/Oatps capable 
of MC transport in the BBB, the expression of 
OATPs/Oatps in neurons and MC congener 
neurotoxicity still remain elusive. In view of the 
scarcity of human primary neurons, we used 
mouse primary neurons to determine the iden-
tity of mOatps expressed, to confirm mOatp-
mediated MC congener-specific uptake, and to 
determine MC congener–specific inhibition of 
neuronal PPs.
Materials and Methods
Materials. We obtained [3H]taurocholate 
(TC; 170.2 GBq/mmol) and [3H]estrone sul-
fate ammonium salt (ES; 2,120 GBq/mmol) 
from PerkinElmer Life and Analytical Sciences 
(Boston, MA, USA). MC congeners were from 
Alexis Biochemicals (Lausen, Switzerland), and 
reverse-transcriptase polymerase chain reaction 
(RT-PCR) chemicals were from Fermentas 
(St. Leon-Roth, Germany). All other chemicals 
and anti  bodies, unless other  wise stated, were 
from Sigma-Aldrich (Taufkirchen, Germany). 
Cell culture media and reagents were obtained 
from PAA Laboratories (Cölbe, Germany).
Isolation and cultivation of primary neu‑
rons. Specific pathogen-free Balb/c mice were 
obtained from the Jackson Laboratory (Bar 
Harbor, ME, USA) and held at the animal 
facility at the University of Konstanz under 
standard conditions. Sacrifice and organ 
removal were carried out humanely and with 
regard for alleviation of suffering in accor-
dance with the German Animal Protection 
Law, approved by the Regierungspräsidium 
in Freiburg, Germany (registry no. T-07 05). 
Primary murine cerebellar granule neurons 
(Skaper et al. 1996) were isolated and cul-
tured as described previously (Volbracht et al. 
1999). Briefly, cerebelli from 6- to 7-day-old 
pups were removed, cells were separated, and 
2.0 × 106 cells/mL were seeded in poly-l-lysine 
(50 mg/L)–coated plates using basal medium 
Eagle (BME), supplemented with 10% fetal 
calf serum, 20 mM potassium chloride, and 
1% penicillin-streptomycin and cultured at 
37°C in 5% carbon dioxide. Medium con-
taining 10 µM cytosine arabinoside to inhibit 
growth of glial cells was added after the initial 
24 hr, and cells were grown for 3 days without 
further medium exchange.
Western blot (WB) analysis for MC‑LR 
detection. Neurons were exposed to varying 
MC-LR concentrations for 48 hr, and 30 µg 
of each sample was prepared for WB analysis 
as previously described (Feurstein et al. 2009). 
We used anti-MC-LR [polyclonal rabbit anti-
MCLR#2; 1:500 (Mikhailov et al. 2001)] as 
the primary anti  body, anti-glyceraldehyde-
3-phosphate dehydrogenase (anti-GAPDH; 
monoclonal mouse anti-GAPDH, 1:30,000) 
as a house  keeping control protein, and horse-
radish peroxidase–conjugated secondary anti-
bodies [rabbit anti-mouse (1:80,000) and goat 
anti-rabbit (1:160,000)]
PP activity after exposure to single MC 
congeners. Cells were exposed to varying con-
centrations of single MC congeners for 48 hr 
and solubilized in 50 µL enzyme solution buf-
fer [0.08 M Tris-HCl (pH 7.0), 0.19 mM 
ethylene glycol tetraacetic acid, 20 mM dithio-
threitol (DTT; in 0.01 M sodium acetate, pH 
5.2), 10 mM manganese chloride (MnCl2)]. 
Protein concentrations were determined using 
the method of Bradford (1976). Subsequently, 
20 µL of each sample (containing 10 µg total 
protein) was transferred to a 96-well plate, and 
an equal volume of water was added. To deter-
mine PP activity, 200 µL freshly prepared and 
prewarmed (37°C) substrate solution contain-
ing reaction buffer [0.25 M Tris-HCl (pH 8.1), 
10 mM MnCl2, 0.2 M magnesium chloride, 
5 mg/mL bovine serum albumin (BSA)], 
60 mM p-nitrophenyl phosphate (pNPP; 
Acros Organics, Morris Plains, NJ, USA), and 
20 mM DTT were added and immediately 
meas  ured at 405 nm (TECAN infinite M200; 
TECAN, Craislheim, Germany) to deter-
mine the 0-time value. After incubation for 
90 min at 37°C, we calculated total PP activity 
of MC-exposed neurons by determining the 
percent loss of pNPP substrate turnover from 
untreated cells (100% PP activity). Individual 
samples were analyzed in triplicate (n = 3), each 
with technical duplicates.
Determination of mOatp mRNA expres‑
sion in primary neurons. Total RNA was iso-
lated using the RNeasy Mini Kit (Qiagen, 
Hilden, Germany) according to manufac-
turer’s instructions. RT-PCR was carried out 
in a final volume of 20 µL containing 10.5 µL 
total RNA (0.5 µg) diluted in RNase-free 
water, 1 µL random hexamer primer (50 µM), 
and 1 µL oligo(dT) (50 µM). The mixture 
was incubated at 70°C for 10 min to pro-
mote primer annealing. Subsequently, 5× 
reaction buffer (4 µL), 1 µL deoxy  nucleoside-
triphosphate mix (10 mM and 2 µL DTT 
(0.1 M) were added and incubated at 42°C 
for 2 min. Finally, cDNA synthesis was car-
ried out using 0.5 µL SuperScript II (100 U; 
Invitrogen, Karlsruhe, Germany) for 50 min at 
42°C, followed by an inactivation for 15 min 
at 70°C. PCR was performed in 20 µL reac-
tion mixtures according to Mühlhardt (2002), 
with minor modifications. Specific primers for 
mOatps [see Supplemental Material, Table 1 
(doi:10.1289/ehp.0901289)] were designed 
using Primer3 software, version 0.4.0 (Rozen 
and Skaletzky 2000). mOatp amplification 
was carried out by mixing 1 µL cDNA prod-
uct and using the following cycling conditions 
for all reactions: 4.5 min at 95°C, 35 cycles 
of 30 sec at 95°C, 1 min at 59°C, 1 min at 
72°C, 1 min at 95°C, and 1 min at 55°C. 
Finally, each PCR product was separated by 
gel electrophoresis on a 3% agarose gel buff-
ered in 10.8 g/L Tris-base, 5.5 g/L boric acid, 
and 4 mL (vol/vol) 0.5 M EDTA, pH 8.0. 
We used DNA ladder (GeneRuler 100bp; 
Fermentas, St. Leon-Rot, Germany) to deter-
mine the PCR product size. Gels were stained 
by ethidium bromide, visualized, and then 
scanned for documentation.
WB analysis for mOatp detection. Primary 
mouse neurons were homogenized, subjected 
to mOatp-WB analysis, and visualized using 
chemiluminescence, as previously described 
(Feurstein et al. 2009). Homogenates of 
murine whole brains and livers served as posi-
tive controls for mOATP expression. Briefly, 
separated protein samples (15 µg) were trans-
ferred to a nitro  cellulose membrane. Polyclonal 
goat anti  bodies against OATP-D (mOatp3a1), 
OATP-3 (mOatp1a5), OATP-E (mOatp4a1), 
OATP-F (mOatp1c1), OATP-B (mOatp2b1) 
(1:100; all from Santa Cruz Biotechnology, 
Santa Cruz, CA, USA), and mOatp1b2 
(1:1,000; kindly provided by C.D. Klaassen, 
University of Kansas Medical Center, Kansas 
City, KS, USA), and monoclonal mouse anti-
β-actin (1:1,000) were used as primary anti-
bodies and incubated for 16 hr at 4°C. The 
horseradish peroxidase–conjugated secondary 
antibodies—goat anti-rabbit (1:160,000), goat 
anti-mouse (1:80,000), and rabbit anti-goat 
(1:80,000)—were incubated for 1 hr at room 
temperature (RT). Immunoreactive bands 
were detected by enhanced chemilumines-
cence (ECL Plus; GE Healthcare, Munich, 
Germany).
Immunocytochemistry for mOatp1b2 
detection. Cells were fixed in 4% para-
formaldehyde for 15 min at RT, permeabi-
lized (0.2% Triton X-100), and subsequently 
incubated with blocking buffer [phosphate-
buffered saline (PBS) containing 1% BSA] for 
1 hr at RT. Polyclonal rabbit anti-mOatp1b2 
(1:800) was applied, and slides were incubated 
for 16 hr at 4°C. Secondary fluorochrome-
conjugated goat anti-rabbit Alexa Fluor 647 
antibody (Invitrogen) was applied in a 1:1,000 
dilution and incubated for 1 hr at RT. Nuclei 
were counterstained with 2.5 µM Hoechst 
33342 (Invitrogen) for 10 min at RT. Finally, 
slides were visualized using an Axiovert 200M 
microscope (Zeiss, Göttingen, Germany).
TC and ES uptake studies. The transport 
capacity and potential functionality of neuronal Feurstein et al.
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mOatps were assessed using [3H]TC and   
[3H]ES uptake. [3H]TC and [3H]ES are well-
characterized substrates for and thus trans-
ported by a variety of OATPs/Oatps (Konig 
et al. 2006; van Montfoort et al. 2003). 
Uptake experiments were initiated by addi-
tion of 500 µL BME medium pre  warmed 
to 37°C and containing varying concentra-
tions of either [3H]TC (3.7 kBq/mL) or   
[3H]ES (3.7 kBq/mL) and unlabeled TC (7, 
40, 60, 80, and 100 µM) and ES (7, 10, 
20, 30, 40, and 50 µM), respectively. After 
30 min exposure at 37°C, uptake was stopped 
by removing the medium and performing 
a subsequent washing step using 3× 1.5 mL 
ice-cold PBS per well. Neurons were solubi-
lized with 500 µL 0.2 normal sodium hydrox-
ide per well (15 min), and the solution was 
neutralized with 500 µL 0.2 normal HCl. 
Solubilized neurons were mixed with 10 mL 
scintillation cocktail (Ready Safe; Beckman 
Coulter, Krefeld, Germany), and radio  activity 
was determined in a liquid scintillation coun-
ter (LS 6500; Beckman Coulter). To normal-
ize radio  activity per milligram of protein, we 
determined protein concentration according 
to the method of Bradford (1976). Individual 
samples were analyzed in triplicate (n = 3), 
each with tech  nical duplicates.
MC congener–dependent inhibition of TC/
ES uptake. Uptake inhibition experiments 
were carried out as described above, but using 
500 µL BME medium containing either 7 µM 
of a mixture of [3H]TC (3.7 kBq/mL) and TC 
or 7 µM of a mixture of [3H]ES (3.7 kBq/mL) 
and ES in the absence or presence of single MC 
congeners (7 µM). To normalize radio  activity 
per milligram of protein, we determined 
protein concentration as described above. 
Individual samples were analyzed in triplicate 
(n = 3), each with technical duplicates.
Data analysis. We performed statistical 
analysis by one-way analysis of variance with 
Dunnett’s post  test using GraphPad Prism 
4.03 (GraphPad Software Inc., La Jolla, CA, 
USA). The level of statistical significance was 
set at p < 0.05 or p < 0.01.
Results
Confirmation of intracellular MC‑LR. We con-
firmed MC-LR uptake into murine neurons   
by MC-LR WB analysis (Figure 1), which 
suggests cellular uptake of MC-LR. The single 
MC-LR–positive band, with an approximate 
molecular weight of 39 kDa, corresponded to 
the expected size of the PP1 (37.5 kDa) and 
PP2A (36 kDa) catalytic subunits with cova-
lently bound MC-LR (1 kDa).
Intracellular PP inhibition by MCs. 
We directly confirmed MC congener trans-
port into neurons using a colorimetric PP 
inhibition assay. At low MC concentrations 
(0.31–1.25 µM), the inhibitory effect of all 
MC congeners was comparable and resulted 
in a 20% reduction of PP activity compared 
with control (Figure 2). At 2.5 µM MC-LR, 
MC-LW, or MC-LF, total PP activity was 
reduced by 25%, 30%, and 60%, respectively, 
whereas 5 µM MC-LF reduced total PP   
activity by 65%.
Determination of mOatp expression in 
primary murine neurons.  We detected 
specific mRNA expression for 12 of 15 
mOatps, as demonstrated by individual 
single positive bands (Figure 3) corre-
sponding to the expected size of the ampli-
fied products (mOatp1a1, 1a4, 1a5, 1a6, 
1b2, 1c1, 2a1, 2b1, 3a1, 4a1, 4c1, and 
5a1). No mRNA expression was found for 
the three members of the mOatp6 family 
(mOatp6b1, 6c1, and 6d1). Water and RT- 
negative controls indicated no contamination/
bands (data not shown).
We analyzed mOatp expression at the 
protein level by WB using crude membrane 
fractions of primary murine neurons, as well 
as mouse liver and brain homogenates. The 
expression of mOatp1b2 and mOatp1a5 was 
confirmed in neurons (Figure 4A,B) with 
immuno  positive bands at approximately 
80 and 60 kDa and 85 and 65 kDa, respec-
tively. Expression of mOatp2b1 (Figure 4C), 
mOatp3a1  (Figure  4D),  mOatp1c1 
(Figure 4E), and mOatp4a1 (Figure 4F) was 
either absent or less than the limit of detec-
tion for the crude neuron membrane extract 
we used.
We also assessed the expression and locali-
za  tion of mOatp1b2 in neurons via immuno-
cytochemistry, which revealed immuno  positive 
staining in membranes of the peri  karyon as 
well as in neurites of cultured cells (Figure 4G). 
No unspecific binding of the fluorochrome-
conjugated secondary antibody to neurons 
(negative control) was found (Figure 4H).
Inhibition of TC/ES uptake by MC   
con  geners. No typical substrate uptake curve 
resulted using either of the two Oatp/OATP 
substrates, TC and ES (Figure 5A,B). More-
over, contrary to expectations, even at the 
highest TC and ES concentrations (189 and 
567 µM, respectively), no saturation of mOatps 
with substrate could be demon  strated (data not 
shown); this suggests unspecific binding of both 
TC and ES to neuronal cells (Figure 5A,B), 
effectively preventing detection of specific satu-
rable uptake if present. Independent of the lat-
ter observations, TC and ES uptake in neurons 
appeared to be inhibited by MC-LR, MC-LW, 
and MC-LF. Although statistically not signifi-
cant, TC uptake tended to be inhibited, irre-
spective of the MC congener used (Figure 5C). 
In contrast, whereas inhibition of ES uptake 
by MC-LR or MC-LW was similarly lower, as 
observed for TC, a statistically significant inhi-
bition (45% of control) of ES uptake occurred 
with MC-LF (Figure 5D).
Discussion
Eriksson et al. (1987) demonstrated that a 
cyclic peptide toxin isolated from the cyano-
bacterium Microcystis aeruginosa presented 
Figure 1. Intracellular- and concentration-depen-
dent detection of MC-LR by WB analysis of neu-
rons exposed to MC-LR for 48 hr; 30 µg total protein 
per lane. Abbreviations: –C, untreated neurons; +C, 
1 µM MC-LR was added to a neuronal homogenate. 
– C+  C
MC-LR 
[µM]
39 kDa
37 kDa
anti-MC-LR
anti-GAPDH
1 0.2 0.4 0.6 0.8
Figure 2. Total PP activity of primary neurons 
after 48 hr exposure to MC-LR, MC-LW, or MC-LF. 
Individual samples were analyzed in triplicate 
(n = 3), each with technical duplicates; data are 
mean ± SEM expressed as percent of control 
(untreated cells; 100% PP activity). 
*p < 0.05. **p < 0.01.
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with a cell-type–specific cytotoxicity; they later 
showed that a multi  specific bile acid transport 
system is involved in the uptake of MC-LR 
into primary rat hepato  cytes (Eriksson et al. 
1990). More recently, it was conclusively 
demon  strated that OATPs/Oatps are respon-
sible for transporting MC-LR (Fischer et al. 
2005, 2010; Komatsu et al. 2007; Lu et al. 
2008; Meier-Abt et al. 2007). However, not 
all OATPs/Oatps are capable of transport-
ing MC-LR (Fischer et al. 2005). Moreover, 
OATPs/Oatps decisively differ in their abil-
ity to transport the structurally variant MC 
congeners (Feurstein et al. 2009; Fischer et al. 
2010; Monks et al. 2007). Thus, the poten-
tial neuro  toxicity of individual MC congeners 
largely depends on the functional expression of 
OATPs/Oatps at the BBB/blood–cerebrospinal 
fluid barrier (Bronger et al. 2005; Huber et al. 
2007; Westholm et al. 2009) and in the neu-
ronal cell membrane. Another prerequisite is 
that OATPs/Oatps are capable of transporting 
MC congeners across these barriers.
Using the mouse as a human surro  gate, 
we demonstrated the mRNA expression of 
12 mOatps in primary murine neurons 
(Figure 3). However, we detected only two 
(mOatp1b2 and mOatp1a5) of six tested 
mOatps in neuronal membranes at the protein 
level (Figure 4A,B). Indeed, WB analysis of 
mOatp1b2 and mOatp1a5 showed two posi-
tive bands, at approximately 80 and 60 kDa 
and 85 and 65 kDa, respectively, most likely 
representing the double bands of mOatps 
described in the literature as glycosilated/
deglycosilated variants of the corresponding 
transporter (Hagenbuch and Meier 2004; 
Komatsu et al. 2007; Zaher et al. 2008). We 
assume that the absence of detectable pro-
tein expression in WB analyses of the other 
mOatps expressed at the mRNA level results 
either from expression levels that are too low 
to allow detection with the amount of crude 
neuron membrane extract used or from the 
complete absence of functional expression in 
neuronal membranes. Beyond the mOatps 
analyzed, the limited number of additional 
commercially available mOatp antibodies pre-
vented detection of other mOatps possibly 
expressed in neuronal membranes. 
Despite the proven expression of mOatp1b2   
and mOatp1a5 in neuronal cells, and con-
trary to expectations and previous experience 
in transfected and primary cells and oocytes 
(Fischer et al. 2005, 2010), we found no satu-
rable transport with the Oatp/OATP sub-
strates TC and ES (Figure 5A,B). Although 
at first glance this seems contradictory, the 
latter observations may stem from experi-
mental problems, for example, unspecific 
binding of TC and ES to neuronal mem-
branes that prevented detection of saturable 
transport of mOatps expressed at very low 
levels (Figure 4). Indeed, evidence that mOatp- 
mediated transport of TC, ES, and MC con-
geners occurred stems from three separate 
lines of experimental data.
First, we detected covalently bound MC-LR   
by WB analysis of mouse neuron homoge-
nate preparations after exposure to MC-LR 
(Figure 1). The bands detected corresponded 
to the molecular weights of the catalytic sub-
units of PP1 and PP2A with covalently bound 
MC-LR and were comparable to those for 
mice and murine whole brain cells reported 
previously by Lu et al. (2008) and Feurstein 
et al. (2009). Using MC-LR–treated wild-type 
and MC-LR–treated Oatp1b2–/– mice, Lu 
et al. (2008) demonstrated that mOatp1b2 is a 
Figure 4. WB analysis in neuronal membrane frac-
tions (A–F) and immuno  detection of mOatp1b2 
in cultured neurons (G,H). M, protein marker. 
(A–F) WB analysis of mOatp1b2 (A), mOatp1a5 (B), 
mOatp2b1 (C), mOatp3a1 (D), mOatp1c1 (E), and 
mOatp4a1 (F). Liver and brain membrane frac-
tions were used as positive controls, and β-actin 
was a loading control. (G,H) Immunodetection 
of mOatp1b2 in cultured neurons treated with 
(G) Hoechst (blue), rabbit anti-mOatp1b2, and fluo-
rochrome-conjugated secondary antibody (red) or 
(H) Hoechst and fluorochrome-conjugated second-
ary antibody only (negative control).
Anti-mOatp1b2
Anti-mOatp1a5
Anti-mOatp2b1
Anti-mOatp3a1
Anti-mOatp1c1
Anti-mOatp4a1
Anti-β-actin
97 kDa
95 kDa
55 kDa
95 kDa
55 kDa
95 kDa
55 kDa
95 kDa
55 kDa
95 kDa
55 kDa
55 kDa
36 kDa
Neuronal (15 µg)
Neuronal (15 µg)
Liver (15 µg)
Liver (15 µg)
Brain (15 µg)
Liver (30 µg)
66 kDa
M
M
Figure 5. Uptake of [3H]TC (A) and [3H]ES (B) in neurons and the inhibitory effect of MC-LR, MC-LW, and 
MC-LF on uptake of [3H]TC (C) and [3H]ES (D). (A and B) Neurons were exposed to varying concentrations 
of labeled/unlabled TC and ES. (C and D) Cells were exposed to [3H]TC plus TC (7 µM; C) or [3H]ES plus ES 
(7 µM; D) in the absence (control; Con) or presence of a single MC congener (7 µM). The inhibitory effect 
was calculated by determining the percent loss of co-incubated versus TC- or ES-exposed neurons (100% 
uptake). Individual samples were analyzed in triplicate (n = 3), each with technical duplicates; data are 
mean ± SEM. 
*p < 0.05. 
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critical carrier of MC-LR in liver, but they also 
highlighted the fact that other mOatps can 
contribute to the hepatic uptake of MC-LR.
Second, variant MC transport by mOatps 
was suggested in the mouse neuron uptake 
inhibition experiments when we used the 
well-characterized OATP/Oatp substrates 
TC and ES. Because all of the OATPs/Oatps 
known to transport MC-LR are also estab-
lished transporters of TC and ES (Konig 
et al. 2006; van Montfoort et al. 2003), it 
is not surprising that coincubations of TC 
or ES with equi  molar concentrations of 
MC-LR, MC-LW, and MC-LF appeared to 
reduce uptake of TC and ES (Figure 5C,D). 
Contrary to expectations from previous 
experiments using primary human hepato-
cytes and OATP-transfected HEK293 cells 
(Fischer et al. 2010), the overall reduction in 
substrate uptake mediated by all MC conge-
ners appeared to be at best marginal for TC, 
whereas we observed an effect with MC-LF 
for the reduction of ES uptake. The latter 
corroborates earlier findings by Fischer et al. 
(2010) that MC-LF is taken up more rapidly 
or efficiently by OATP1B family members 
than are other MC congeners. 
Third, MC-LR, MC-LW, and MC-LF 
have been reported to have comparable toxico-
dynamic properties (PP inhibition) (Monks 
et al. 2007). In the present study, MC-LF 
induced the greatest reduction in PP activity 
after exposure of neuronal cells to equi  molar 
concentrations of the three MC congeners 
(Figure 2), which suggests that MC-LF was 
transported more efficiently into the cell 
(toxico  kinetics) and thus reached PP-inhibitive 
intra  cellular concentrations more quickly than 
did MC-LR and MC-LW. As noted above, 
more efficient transport of MC-LF was previ-
ously reported in OATP1B1- and OATP1B3-
transfected HEK293 cells and primary human 
hepatocytes (Fischer et al. 2010), OATP-
transfected HeLa cells (Monks et al. 2007), 
and murine whole-brain cells containing a mix-
ture of neuronal cells, astrocytes, and microglia 
(Feurstein et al. 2009).
However, despite the evidence presented 
above suggesting neuronal uptake of MCs, 
it has yet to be elucidated whether oral MC 
exposure leads to neurotoxicity in mice in vivo. 
The relevance for the human situation is that, 
irrespective of the fact that our experiments 
were carried out in mouse primary neuronal 
cells and that mice are mere surrogates for 
humans, all experiments performed in this 
study employed relevant MC concentrations 
compared with those detected in the serum of 
human patients in Caruaru after exposure to 
MCs through dialysis water. 
Moreover, the observations in primary 
murine neuronal cells presented here corre-
spond well with earlier findings of OATP-
mediated MC transport and cyto  toxocity in 
primary human liver cells and OATP1B1‑ and 
OATP1B3-transfected HEK293 cells (Fischer 
et al. 2010). The latter lines of evidence thus 
strongly support the assumption at the out-
set that MC-induced neuro  toxicity may have 
been involved in the neurological dysfunctions 
observed in Caruaru patients.
Conclusion
All together, the data presented here strongly 
suggest that mOatps, albeit not exclusively 
mOatp1b2, are involved in the neuronal 
uptake of MCs and that the uptake and 
sub  sequent neurotoxicity are MC congener 
dependent. Provided these observations—
including the higher potential toxicity of 
MC-LF—can be extrapolated to humans, 
as suggested by the findings of Fischer 
et al. (2010) from their experiments in pri-
mary human hepatocytes, these results not 
only explain the observed neurotoxicity 
in the Caruaru accident but also highlight 
the problems of using only one MC con-
gener, MC-LR (Grosse et al. 2006; World 
Health Organization 1999), as the basis for 
MC-related human risk assessment.
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